Chimera Investment Corporation 8.875% Senior Notes due 2030 financials
$25.00−0.12%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $0.00 |
| Gross profit | $0.00 |
| Gross margin | — |
| Operating income | -$154.0M |
| Net income | $144.5M |
| Net margin | — |
| Diluted EPS | $1.72 |
| EBITDA | -$146.8M |
| Operating cash flow | -$248.9M |
| Free cash flow | -$248.9M |
| Diluted shares | 83.9M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $278.6M |
| Short-term investments | $14.08B |
| Total debt | $13.07B |
| Total assets | $15.81B |
| Total liabilities | $13.24B |
| Shareholders' equity | $2.57B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology